Pluri Announced The Publication Of An Article Related To PLX-R18 In A Peer-reviewed Journal Nature Bone Marrow Transplantation, Showing PLX-R18 Increases Blood Cell Counts, Reduces Need For Transfusions In A Phase 1 Study
Portfolio Pulse from Benzinga Newsdesk
Pluri has published an article in the peer-reviewed journal Nature Bone Marrow Transplantation, demonstrating that PLX-R18 increases blood cell counts and reduces the need for transfusions in a Phase 1 study.
August 16, 2023 | 11:18 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pluri's PLX-R18 has shown positive results in a Phase 1 study, which could potentially boost the company's stock in the short term.
The positive results from the Phase 1 study of PLX-R18, as published in a reputable journal, could increase investor confidence in Pluri, potentially leading to a short-term increase in the company's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100